|
1
|
Zhang J and Winoto A: A mouse
Fas-associated protein with homology to the human Mort1/FADD
protein is essential for Fas-induced apoptosis. Mol Cell Biol.
16:2756–2763. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chinnaiyan AM, O'Rourke K, Tewari M and
Dixit VM: FADD, a novel death domain-containing protein, interacts
with the death domain of Fas and initiates apoptosis. Cell.
81:505–512. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kuang AA, Diehl GE, Zhang J and Winoto A:
FADD is required for DR4- and DR5-mediated apoptosis: Lack of
trail-induced apoptosis in FADD-deficient mouse embryonic
fibroblasts. J Biol Chem. 275:25065–25068. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chinnaiyan AM, Tepper CG, Seldin MF,
O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME and
Dixit VM: FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and
tumor necrosis factor receptor-induced apoptosis. J Biol Chem.
271:4961–4965. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yeh WC, de la Pompa JL, McCurrach ME, Shu
HB, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, et
al: FADD: Essential for embryo development and signaling from some,
but not all, inducers of apoptosis. Science. 279:1954–1958. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kabra NH, Kang C, Hsing LC, Zhang J and
Winoto A: T cell-specific FADD-deficient mice: FADD is required for
early T cell development. Proc Natl Acad Sci USA. 98:6307–6312.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang J, Cado D, Chen A, Kabra NH and
Winoto A: Fas-mediated apoptosis and activation-induced T-cell
proliferation are defective in mice lacking FADD/Mort1. Nature.
392:296–300. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang H, Zhou X, McQuade T, Li J, Chan FK
and Zhang J: Functional complementation between FADD and RIP1 in
embryos and lymphocytes. Nature. 471:373–376. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Osborn SL, Diehl G, Han SJ, Xue L, Kurd N,
Hsieh K, Cado D, Robey EA and Winoto A: Fas-associated death domain
(FADD) is a negative regulator of T-cell receptor-mediated
necroptosis. Proc Natl Acad Sci USA. 107:13034–13039. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Welz PS, Wullaert A, Vlantis K, Kondylis
V, Fernández-Majada V, Ermolaeva M, Kirsch P, Sterner-Kock A, van
Loo G and Pasparakis M: FADD prevents RIP3-mediated epithelial cell
necrosis and chronic intestinal inflammation. Nature. 477:330–334.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Newton K, Harris AW and Strasser A:
FADD/MORT1 regulates the pre-TCR checkpoint and can function as a
tumour suppressor. EMBO J. 19:931–941. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tourneur L, Delluc S, Lévy V, Valensi F,
Radford-Weiss I, Legrand O, Vargaftig J, Boix C, Macintyre EA,
Varet B, et al: Absence or low expression of fas-associated protein
with death domain in acute myeloid leukemia cells predicts
resistance to chemotherapy and poor outcome. Cancer Res.
64:8101–8108. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fantl V, Smith R, Brookes S, Dickson C and
Peters G: Chromosome 11q13 abnormalities in human breast cancer.
Cancer Surv. 18:77–94. 1993.PubMed/NCBI
|
|
14
|
Gibcus JH, Menkema L, Mastik MF, Hermsen
MA, de Bock GH, van Velthuysen ML, Takes RP, Kok K, Marcos CA
Alvarez, van der Laan BF, et al: Amplicon mapping and expression
profiling identify the Fas-associated death domain gene as a new
driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer. Clin
Cancer Res. 13:6257–6266. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Prapinjumrune C, Morita K, Kuribayashi Y,
Hanabata Y, Shi Q, Nakajima Y, Inazawa J and Omura K: DNA
amplification and expression of FADD in oral squamous cell
carcinoma. J Oral Pathol Med. 39:525–532. 2010.PubMed/NCBI
|
|
16
|
Rasamny JJ, Allak A, Krook KA, Jo VY,
Policarpio-Nicolas ML, Sumner HM, Moskaluk CA, Frierson HF Jr and
Jameson MJ: Cyclin D1 and FADD as biomarkers in head and neck
squamous cell carcinoma. Otolaryngol Head Neck Surg. 146:923–931.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kwek SS, Roy R, Zhou H, Climent J,
Martinez-Climent JA, Fridlyand J and Albertson DG: Co-amplified
genes at 8p12 and 11q13 in breast tumors cooperate with two major
pathways in oncogenesis. Oncogene. 28:1892–1903. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen G, Bhojani MS, Heaford AC, Chang DC,
Laxman B, Thomas DG, Griffin LB, Yu J, Coppola JM, Giordano TJ, et
al: Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and
is associated with poor outcome in lung adenocarcinomas. Proc Natl
Acad Sci USA. 102:12507–12512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Andrán-Sandberg A: Pancreatic cancer:
Chemotherapy and radiotherapy. N Am J Med Sci. 3:1–12. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
King KL and Cidlowski JA: Cell cycle
regulation and apoptosis. Annu Rev Physiol. 60:601–617. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Varfolomeev E, Maecker H, Sharp D,
Lawrence D, Renz M, Vucic D and Ashkenazi A: Molecular determinants
of kinase pathway activation by Apo2 ligand/tumor necrosis
factor-related apoptosis-inducing ligand. J Biol Chem.
280:40599–40608. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheng W, Wang L, Zhang R, Du P, Yang B,
Zhuang H, Tang B, Yao C, Yu M, Wang Y, et al: Regulation of protein
kinase C inactivation by Fas-associated protein with death domain.
J Biol Chem. 287:26126–26135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Arlt A, Vorndamm J, Breitenbroich M,
Fölsch UR, Kalthoff H, Schmidt WE and Schäfer H: Inhibition of
NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis
induced by etoposide (VP16) or doxorubicin. Oncogene. 20:859–868.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Alappat EC, Feig C, Boyerinas B, Volkland
J, Samuels M, Murmann AE, Thorburn A, Kidd VJ, Slaughter CA, Osborn
SL, et al: Phosphorylation of FADD at serine 194 by CKIalpha
regulates its nonapoptotic activities. Mol Cell. 19:321–332. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheng W, Wang L, Yang B, Zhang R, Yao C,
He L, Liu Z, Du P, Hammache K, Wen J, et al: Self-renewal and
differentiation of muscle satellite cells are regulated by the
Fas-associated death domain. J Biol Chem. 289:5040–5050. 2014.
View Article : Google Scholar : PubMed/NCBI
|
